Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Spinal cord size as promising biomarker of disability outcomes after hematopoietic stem cell transplantation in multiple sclerosis.
Mariottini A, Stack EH, Nair G, Nozzoli C, Wu T, Marchi L, Boncompagni R, Repice AM, Fainardi E, Pasquale FD, Carlesi E, Saccardi R, Jacobson S, Massacesi L. Mariottini A, et al. Among authors: boncompagni r. Mult Scler Relat Disord. 2024 Aug;88:105745. doi: 10.1016/j.msard.2024.105745. Epub 2024 Jun 26. Mult Scler Relat Disord. 2024. PMID: 38996712 Free article.
Cost and effectiveness of autologous haematopoietic stem cell transplantation and high-efficacy disease-modifying therapies in relapsing-remitting multiple sclerosis.
Mariottini A, Nozzoli C, Carli I, Landi F, Gigli V, Repice AM, Ipponi A, Cecchi M, Boncompagni R, Saccardi R, Massacesi L. Mariottini A, et al. Among authors: boncompagni r. Neurol Sci. 2024 Jul;45(7):3379-3387. doi: 10.1007/s10072-024-07308-y. Epub 2024 Jan 26. Neurol Sci. 2024. PMID: 38277051 Free PMC article.
Leptomeningeal enhancement in multiple sclerosis: a focus on patients treated with hematopoietic stem cell transplantation.
Marchi L, Mariottini A, Viti V, Bianchi A, Nozzoli C, Repice AM, Boncompagni R, Ginestroni A, Damato V, Barilaro A, Chiti S, Saccardi R, Fainardi E, Massacesi L. Marchi L, et al. Among authors: boncompagni r. Front Neurol. 2024 Jun 5;15:1373385. doi: 10.3389/fneur.2024.1373385. eCollection 2024. Front Neurol. 2024. PMID: 38899059 Free PMC article.
Novel Drug Combinations and Donor Lymphocyte Infusions Allow Prolonged Disease Control in Multiple Myeloma Patients Relapsing after Allogeneic Transplantation.
Nozzoli C, Pucillo M, Giaccone L, Rambaldi A, Stanghellini MTL, Benedetti E, Russo D, Mordini N, Mangiacavalli S, Bernasconi P, Parma M, Carluccio P, Galieni P, Rivela P, Martino M, Chiusolo P, Isola M, De Martino M, Oldani E, Degrandi E, Boncompagni R, Antonioli E, Carnevale F, Tozzi M, Selleri C, Fanin R, Patriarca F; Gruppo Italiano Trapianto Midollo Osseo (GITMO). Nozzoli C, et al. Among authors: boncompagni r. Transplant Cell Ther. 2025 Jan;31(1):26.e1-26.e13. doi: 10.1016/j.jtct.2024.10.015. Epub 2024 Nov 4. Transplant Cell Ther. 2025. PMID: 39505212
The BLIND study: blinatumomab and DLI approach for management of B-ALL relapse after allogeneic stem cell transplantation. A multicentric Italian experience.
Giammarco S, Maggi R, Di Marino L, Chiusolo P, Teofili L, Piccirilo N, Metafuni E, Limongiello MA, Leotta S, Milone G, Cupri A, Cutini I, Saccardi R, Nozzoli C, Boncompagni R, Gozzini A, Scappini B, Piccini M, Fracchiolla NS, Sica S. Giammarco S, et al. Among authors: boncompagni r. Bone Marrow Transplant. 2024 Nov 21. doi: 10.1038/s41409-024-02475-0. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 39567768 No abstract available.
14 results